Mikanokryptin
Mikanokryptin
Mikanokryptin
Communications Chemie
Angew. Chem. Int. Ed. 2017, 56, 1 – 6 ! 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 1
!
!
Scheme 2. Gram-scale total synthesis of (+)-mikanokryptin (1). Reagents and conditions: a) carvone (1 equiv), Na2CO3 (3 equiv), SO2Cl2 (1.2 equiv, added
slowly over 2 h), DCM, 0 8C, then CeCl3·7 H2O (1.1 equiv), NaBH4 (3 equiv), MeOH, 0 8C, 1 h, 78 %; b) TBDPSCl (1.2 equiv), imidazole (3 equiv), DMAP
(0.05 equiv), DMF, room temperature, 8 h, 90 %; c) O3, pyridine (0.3 equiv), DCM, !78 8C, 20–40 min, then DMS (2 equiv), room temperature, 8 h, then
piperidine (0.15 equiv), AcOH (0.2 equiv), 40 8C, 16 h, 42 %; d) In (1.5 equiv), 7 (1.2 equiv), 8 (1 equiv), H2O (1 equiv), DMF, room temperature, 8 h, 67 %,
d.r. 2:1; e) TESOTf (4 equiv), 2,4,6-collidine (6 equiv), DCM, 0 8C, 24 h, 78 %; f) SnCl2 (4.5 equiv), NaI (9 equiv), DMF, 60 8C, 12 h, 90 %; g) NaOMe
(0.1 equiv), MeOH, 16 h, then AcOH (0.1 equiv), PtO2 (0.1 equiv), H2 (1 atm), 6 h, 96 %; h) [Rh(PPh3)3Cl] (0.1 equiv), H2 (1 atm), PhH, 1 h, 54 %; i) TBAF
(3 equiv), THF, room temperature, 24 h; DBU (1.1 equiv), toluene, DCM, D, 69 %; j) MnO2, DCM, room temperature, 16 h, 97 %. DBU = 1,8-diazabicyclo-
[5.4.0]undec-7-ene, DCM = dichloromethane, DMAP = 4-dimethylaminopyridine, DMF = N,N-dimethylformamide, DMS = dimethyl sulfide, TBDPSCl = tert-
butyldiphenylsilyl chloride, TESOTf = triethylsilyl trifluoromethanesulfonate, TBAF = tetra-n-butylammonium fluoride. All X-ray crystal structures shown were
obtained during preliminary studies conducted with (!)-carvone.
tured prominently in this regard, and typical result in related 8,12-guianolides (Scheme 1), a cis arrangement
cyclopentane-containing building blocks in 5–8 synthetic between the C6 hydroxy group and the neighboring acrylate
steps.[13a,c–g, 16a–d] Considering the desire for D4,5 unsaturation, group is required on the future cycloheptane ring. Although
we developed a robust three-step protocol from carvone guaianolides with a trans arrangement of these groups have
(Scheme 2). The isopropenyl group of carvone was first been studied (see geigerin, for example, Scheme 1 A),[10b–d]
chlorinated at the allylic position (SO2Cl2, Na2CO3), and then fewer tactics exist to access this pattern and sometimes rely on
directly subjected to the Luche reduction conditions. This the inversion or epimerization of a trans-configured precur-
one-pot procedure afforded chloro-substituted cis-carveol 5 sor.[19] We were pleased to find that allylic bromide 8, which
reliably on a 30 g scale in approximately 80 % yield. Silylation can be prepared in two steps from commercially available
of 5 with tert-butyldiphenylsilyl chloride cleanly provided silyl materials on a decagram scale, functioned well in this
ether 6 in excellent yield (> 90 %). Inspired by previous work setting.[20, 21] Under indium-mediated conditions, 8 could be
with limonene,[17] ozonolysis of 6 in the presence of catalytic chemoselectively activated in the presence of allylic chloride
quantities of pyridine (0.3 equiv) resulted in chemoselective 7, and was found to cleanly add to the aldehyde moiety to give
cleavage of the trisubstituted olefin under carefully moni- 9 (d.r. 2:1 at C6) in 67 % yield on a 14 g scale. Allylation
tored cryogenic conditions.[18] The sensitive dicarbonyl inter- protocols based on activation with Cr, Zn, Pd, Cd, Sn, Pb, and
mediate thus formed following reductive quenching with Bi were found to be inferior with respect to both yield and
dimethyl sulfide underwent intramolecular aldol condensa- diastereoselectivity.[22] Notably, the incorporation of 1 equiv-
tion in the presence of piperidine and acetic acid to afford alent of H2O proved important; without it, slightly lower
enal 7 in a one-pot procedure. Large quantities of 7 (ca. 100 g) diastereoselectivity was observed as well as extensive in situ
were readily prepared in our laboratory through this three- formation of the 6,12-lactone framework. With larger quanti-
step procedure, which is envisioned to serve as the foundation ties, increased decomposition of 8 was observed. The sensitive
for syntheses of numerous guaianolides with D4,5 unsatura- homoallylic alcohol 9 and the minor diastereomer were then
tion. subjected to the mild deacetalization protocol reported by
With the western fragment completed, we turned toward Fujioka, Kita, and co-workers (TESOTf, 2,4,6-collidine),[23]
the first of two allylation reactions. For mikanokryptin (1) and
2 www.angewandte.org ! 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Angew. Chem. Int. Ed. 2017, 56, 1 – 6
!
!
which also silylated the C6 alcohol, thus leading to 10.[24] At cyclized product was obtained. When all reagents (SnCl2, NaI,
this stage, the minor diastereomer could also be separated. and 10) were simply mixed together and heated in a single
With substrate 10 accessible on large scales, we were well- step (entry 8), a remarkably clean reaction ensued at 60 8C to
positioned to evaluate the second, seven-membered-ring- afford 11 in 90 % yield as a single diastereomer. Notably, this
forming allylation reaction (Table 1). We commenced our reaction was performed on a 7 g scale without a depression in
yield.
With a six-step, multigram-scale synthesis of the full
Table 1: Investigation of metal-mediated allylation conditions for the
synthesis of the 5,7,5-fused guaianolide lactone system. guaianolide skeleton complete, only redox manipulations
were required to complete the target. Chemoselective reduc-
tion of the D10,14 alkene in 11 proved challenging in the
presence of the more reactive a-methylenelactone. In the
presence of the Wilkinson catalyst, only the latter was
reduced to give 13 (Scheme 2). With PtO2/H2, both olefins
could be readily hydrogenated. Taking advantage of the high
reactivity of the a-methylenelactone toward conjugate addi-
Entry Conditions[a] Yield [%][b] tion, we first treated 11 with a catalytic quantity of sodium
11 14 15 rsm[c]
methoxide (10 mol %) in MeOH, and then reduced the
1 CrCl2, cat. NiCl2, DMF, 60 8C 10[d] 17 – – methanol addition product with the Adam catalyst (PtO2,
2 In0, NaI, DMF, 60 8C 13[e] – – – AcOH, H2) in near quantitative yield (96 %) in the same flask.
3[f ] NaI; SmI2, HMPA–THF, !78 8C 27[d] 17 – –
When attempting the global desilylation of 12 (TBAF, THF),
4[f ] NaI; Zn0, aq. NH4Cl, THF, rt 0 51 – 34
5[f ] NaI; Mg0, cat. (CH2Br)2, THF, rt 0 – – –
we noticed that a base-mediated retro-conjugate addition of
6[f ] NaI; iPrMgCl, THF, 0 8C 0 – – – MeOH occurred, thus resulting in a 5:2 mixture of the
7[f ] NaI; SnCl2, DMF, rt 53[e] – 20 9 deprotected conjugated ester and the methanol adduct in
8[g] SnCl2, NaI, DMF, 60 8C 90[e] – – – 83 % yield. When DBU was added to the crude mixture, the
[a] Reactions were performed on a 30 mg scale unless otherwise stated. reaction could be pushed to completion in favor of the
[b] Yield of the isolated product. [c] Recovered starting material. conjugated ester product; thus, the ester was isolated in 69 %
[d] Diastereomeric ratio: 11/8-epi-11 2:1. [e] A single diastereomer was yield on a gram scale. Finally, the addition of freshly activated
obtained. [f] The starting material was first treated with NaI in acetone MnO2 provided mikanokryptin (1) in near-quantitative yield
for 8 h. [g] The reaction was performed on a 7 g scale. through highly chemoselective allylic oxidation. Notably, one
gram of 1 was synthesized in a single pass from (+)-carvone in
6 % overall yield. The absolute configuration of 1 was
confirmed as previously reported (synthetic: [a]D =+ 235.08,
natural: [a]D =+ 2648 (c = 0.098, MeOH)). Moreover, it is
envisioned that intermediate 11, readily accessible in multi-
gram quantities, could serve as a versatile intermediate for the
synthesis of guaianolides containing both D4,5 and D10,14
functionalization.[27]
investigation by exploring the venerable Nozaki–Hiyama– In summary, we have completed a short, enantiospecific,
Kishi (NHK) reaction (entry 1), which has proven efficient in gram-scale total synthesis of mikanokryptin, a complex 8,12-
many syntheses of medium-sized rings.[22a] The desired trans- guaianolide. Although guaianolides have been the subject of
formation proceeded in low yield (10 %) and with moderate numerous synthetic campaigns, most total synthetic routes to
diastereoselectivity (d.r. 2:1). Surprisingly, the major products date have produced low-milligram quantities of material.[28]
formed in this reaction were a mixture of two diastereomeric To the best of our knowledge, this approach represents the
cyclooctanes 14. This competition (eight- versus seven- first gram-scale, fully synthetic entry into this coveted
membered-ring formation) was also observed under sama- sesquiterpene family. Two highly robust and scalable allyla-
rium iodide mediated cyclization conditions with an allylic tion processes were critical in processing large quantities of
iodide substrate, although in this case the formation of the material. Through variations on this strategy, the synthesis of
seven-membered ring to give 11 prevailed slightly (entry 3).[25] other mikanokryptin-type 8,12-guaianolides should be possi-
In contrast, indium- and zinc-mediated conditions were more ble. Such endeavors, in addition to the exploration of
selective for a single product (entries 2 and 4). In the former alternative reagent-controlled allylation methods to enable
case, 11 was afforded as a single diastereomer (13 %), whereas the synthesis of all guaianolide stereochemical patterns, are
the latter produced 14 (51 %), and recovered 10 (34 %). currently under way and will be reported in due course.
Magnesium-based conditions were ineffective for this trans-
formation (entries 5 and 6). Gratifyingly, tin(II) chloride
proved to be a superior reductant.[22h, 26] Finkelstein conver- Acknowledgements
sion of 10 into an allylic iodide, followed by SnCl2-mediated
cyclization, afforded synthetically useful quantities of 11 This research was supported by the NIH (GM116952). T.J.M.
(53 %), along with the recovery of 10, and cycloheptanol 15 is an Alfred P. Sloan Fellow and Cottrel Scholar. Bristol-
(Table 1, entry 7). Notably, only one diastereomer of each Myers Squibb, Amgen, and the UC Berkeley Graduate
Angew. Chem. Int. Ed. 2017, 56, 1 – 6 ! 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.angewandte.org 3
!
!
Division are acknowledged for providing predoctoral fellow- 1975, 14, 1664; c) W. F. Reynolds, R. G. Enriquez, M. A. Chavez,
ships to X.H. S.X. thanks the National Natural Science A. L. Silba, M. A. Martinez, Can. J. Chem. 1985, 63, 849; d) M. J.
Foundation of China (No. 21402149) and the Chinese Bovill, M. H. P. Guy, G. A. Sim, D. N. J. White, W. Herz, J. Chem.
Soc. Perkin Trans. 2 1979, 53.
Scholarship Council (CSC) fellowship program. We thank
[12] a) V. J. Bryan, T. H. Chan, Tetrahedron Lett. 1996, 37, 5341;
Dr. Hasan Celik and Yujia Tao for NMR spectroscopic b) G. A. Molander, J. B. Etter, P. W. Zinke, J. Am. Chem. Soc.
assistance and technical assistance, respectively. Dr. Antonio 1987, 109, 453; c) G. A. Molander, J. A. McKie, J. Org. Chem.
DiPasquale is thanked for X-ray crystallographic analysis, for 1991, 56, 4112; d) L. M. Fleury, A. D. Kosal, J. T. Masters, B. L.
which support from NIH Shared Instrument Grant S10- Ashfeld, J. Org. Chem. 2013, 78, 253.
RR027172 is acknowledged. [13] For single allylation events in guaianolide synthesis, see: a) T. G.
Elford, D. G. Hall, J. Am. Chem. Soc. 2010, 132, 1488; b) S.
Kalidindi, W. B. Jeong, A. Schall, R. Bandichhor, B. Nosee, O.
Reiser, Angew. Chem. Int. Ed. 2007, 46, 6361; Angew. Chem.
Conflict of interest 2007, 119, 6478; c) H. S. Yang, X. X. Qiao, F. Y. Li, H. Ma, L. G.
Xie, X. Xu, Tetrahedron Lett. 2009, 50, 1110; d) H. Yang, Y. Gao,
The authors declare no conflict of interest. X. Qiao, L. Xie, X. Xu, Org. Lett. 2011, 13, 3670; e) B. Wen, J. K.
Hexum, J. C. Widen, D. A. Harki, K. M. Brummond, Org. Lett.
Keywords: allylation · guaianolides · natural products · 2013, 15, 2644; f) S. V. Ley, A. Antonello, E. P. Balskus, D. T.
terpenes · total synthesis Booth, S. B. Christensen, E. Cleator, H. Gold, K. Hogenauer, U.
Hunger, R. M. Myers, S. F. Oliver, O. Simic, M. D. Smith, H.
Sohoel, A. J. Woolford, Proc. Natl. Acad. Sci. USA 2004, 101,
12073; g) S. P. Andrews, M. Ball, F. Wierschem, E. Cleator, S.
Oliver, K. Hçgenauer, O. Simic, A. Antonello, U. H"nger, M. D.
Smith, S. V. Ley, Chem. Eur. J. 2007, 13, 5688.
[1] B. Ivanescu, A. Miron, A. Corciova, J. Anal. Methods Chem.
[14] a) A. Srikrishna, V. H. Pardeshi, G. Satyanarayana, Tetrahedron:
2015, 2015, 247685.
Asymmetry 2010, 21, 746; b) A. Srikrishna, V. H. Pardeshi,
[2] a) M. Chadwick, H. Trewin, F. Gawthrop, C. Wagstaff, Int. J.
Tetrahedron 2010, 66, 8160; c) E. L. Grimm, J. L. Methot, M.
Mol. Sci. 2013, 14, 12780; b) G. F. Padilla-Gonzalez, F. A.
Shamji, Pure Appl. Chem. 2003, 75, 231.
dos Santos, F. B. Da Costa, Crit. Rev. Plant Sci. 2016, 35, 18.
[15] M. Zahel, A. Kessberg, P. Metz, Angew. Chem. Int. Ed. 2013, 52,
[3] a) S. Zhang, Y. K. Won, C. N. Ong, H. M. Shen, Curr. Med.
5390; Angew. Chem. 2013, 125, 5500.
Chem. Anticancer Agents 2005, 5, 239; b) A. Janecka, A.
[16] a) E. Lee, J. W. Lim, C. H. Yoon, Y. S. Sung, Y. K. Kim, M. Yun,
Wyre˛bska, K. Gach, J. Fichna, T. Janecki, Drug Discovery
S. Kim, J. Am. Chem. Soc. 1997, 119, 8391; b) V. Navickas, D. B.
Today 2012, 17, 561.
Ushakov, M. E. Maier, M. Strobele, H. J. Meyer, Org. Lett. 2010,
[4] a) I. Merfort, Curr. Drug Targets 2011, 12, 1560; b) I. H. Hall,
K. H. Lee, C. O. Starnes, Y. Sumida, R. Y. Wu, T. G. Waddell, 12, 3418; c) L. Z. Sun, F. Shah, M. A. Helal, Y. S. Wu, Y. Pedduri,
J. W. Cochran, K. G. Gerhart, J. Pharm. Sci. 1979, 68, 537. A. G. Chittiboyina, J. Gut, P. J. Rosenthal, M. A. Avery, J. Med.
[5] a) L. G. Rocha, J. R. Almeida, R. O. Macedo, J. M. Barbosa- Chem. 2010, 53, 7864; d) T. C. Johnson, M. R. Chin, T. Han, J. P.
Filho, Phytomedicine 2005, 12, 514; b) H. Fuchino, T. Koide, M. Shen, T. Rana, D. Siegel, J. Am. Chem. Soc. 2016, 138, 6068;
Takahashi, S. Sekita, M. Satake, Planta Med. 2001, 67, 647. e) F. L. Manzano, F. M. Guerra, F. J. Moreno-Dorado, Z. D.
[6] a) J. J. Ross, J. T. Arnason, H. C. Birnboim, Planta Med. 1999, 65, Jorge, G. M. Massanet, Org. Lett. 2006, 8, 2879; f) R. Mar!n-
126; b) R. J. Marles, J. Kaminski, J. T. Arnason, L. Pazos-Sanou, Barrios, A. L. Garc!a-Cabeza, F. J. Moreno-Dorado, F. M.
S. Heptinstall, N. H. Fischer, C. W. Crompton, D. G. Kindack, Guerra, G. M. Massanet, J. Org. Chem. 2014, 79, 6501.
D. V. Awang, J. Nat. Prod. 1992, 55, 1044. [17] a) A. Srikrishna, N. C. Babu, Tetrahedron Lett. 2001, 42, 4913;
[7] B. Siedle, A. J. Garc!a-PiÇeres, R. Murillo, J. Schulte-Mçnting, V. b) D. S. Pisoni, D. B. Silva, R. A. Schenato, M. A. Ceschi, J. Braz.
Castro, P. R"ngeler, C. A. Klaas, F. B. Da Costa, W. Kisiel, I. Chem. Soc. 2004, 15, 652.
Merfort, J. Med. Chem. 2004, 47, 6042. [18] Extensive undesired oxidation of the isopropenyl unit was
[8] a) M. R. O. Kreuger, S. Grootjans, M. W. Biavatti, P. Vandena- observed under prolonged reaction times or in the absence of
beele, K. D#Herde, Anti-Cancer Drugs 2012, 23, 883; b) M. M. pyridine.
Chaturvedi, B. Sung, V. R. Yadav, R. Kannappan, B. B. Aggar- [19] For examples, see: a) A. E. Greene, M. T. Edgar, J. Org. Chem.
wal, Oncogene 2011, 30, 1615. 1989, 54, 1468; b) A. Lauridsen, C. Cornett, T. Vulpius, P. Moldt,
[9] For a recent review of guaianolide syntheses, see: A. Santana, S. B. Christensen, Acta Chem. Scand. 1996, 50, 150; c) A.
J. M. G. Molinillo, F. A. Mac!as, Eur. J. Org. Chem. 2015, 2093. Barthel, F. Kaden, A. J%ger, P. Metz, Org. Lett. 2016, 18, 3298.
[10] a) D. H. R. Barton, J. E. D. Levisalles, J. Chem. Soc. 1958, 4518; [20] For the synthesis of 8, see the Supporting Information.
b) D. H. R. Barton, R. J. Wells, J. T. Pinhey, J. Chem. Soc. 1964, [21] A number of other reagents beside 8 were examined for this
2518; c) S. Carret, J.-P. Depr$s, Angew. Chem. Int. Ed. 2007, 46, transformation (see the Supporting Information for details).
6870; Angew. Chem. 2007, 119, 6994; d) G. Valot, J. Garcia, V. [22] a) A. F"rstner, Chem. Rev. 1999, 99, 991; b) Y. Okuda, S.
Duplan, C. Serba, S. Barluenga, N. Winssinger, Angew. Chem. Nakatsukasa, K. Oshima, H. Nozaki, Chem. Lett. 1985, 14, 481;
Int. Ed. 2012, 51, 5391; Angew. Chem. 2012, 124, 5487; e) T. S. L. c) C. Petrier, J. L. Luche, J. Org. Chem. 1985, 50, 910; d) Y. Gao,
Banchelin, S. Carret, A. Giannini, J.-P. Depr$s, Eur. J. Org. X. Wang, L. Sun, L. Xie, X. Xu, Org. Biomol. Chem. 2012, 10,
Chem. 2009, 3678; f) G. Blay, V. Bargues, L. Cardona, B. Garcia, 3991; e) K. Foo, I. Usui, D. C. G. Gçtz, E. W. Werner, D. Holte,
J. R. Pedro, J. Org. Chem. 2000, 65, 6703; g) G. Blay, V. V. P. S. Baran, Angew. Chem. Int. Ed. 2012, 51, 11491; Angew.
Bargues, L. Cardona, A. M. Collado, B. Garc!a, M. C. MuÇoz, Chem. 2012, 124, 11659; f) S. Araki, H. Ito, Y. Butsugan, J.
J. R. Pedro, J. Org. Chem. 2000, 65, 2138; h) T. Hirose, N. Organomet. Chem. 1988, 347, 5; g) J. Nokami, T. Tamaoka, H.
Miyakoshi, C. Mukai, J. Org. Chem. 2008, 73, 1061; i) E. E. Ogawa, S. Wakabayashi, Chem. Lett. 1986, 15, 541; h) P. K.
Anagnostaki, V. P. Demertzidou, A. L. Zografos, Chem. Kalita, P. Phukan, C. R. Chim. 2013, 16, 1055; i) H. Tanaka, S.
Commun. 2015, 51, 2364. Yamashita, T. Hamatani, Y. Ikemoto, S. Torii, Chem. Lett. 1986,
[11] a) W. Herz, A. Srinivasan, P. S. Kalyanaraman, Phytochemistry 15, 1611; j) J. Y. Zhou, Y. Jia, G. F. Sun, S. H. Wu, Synth.
1975, 14, 233; b) W. Herz, P. S. Kalyanaraman, Phytochemistry Commun. 1997, 27, 1899; k) M. Wada, K. Akiba, Tetrahedron
4 www.angewandte.org ! 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Angew. Chem. Int. Ed. 2017, 56, 1 – 6
!
!
Lett. 1985, 26, 4211; l) S. Araki, H. Ito, N. Katsumura, Y. ylation. 11b,13-Dihydroxerantholide has been previously iso-
Butsugan, J. Organomet. Chem. 1989, 369, 291. lated from Pechuel-Loeschea leibnitziae: F. Bohlmann, N.
[23] a) H. Fujioka, Y. Sawama, N. Murata, T. Okitsu, O. Kubo, S. Borthakur, Phytochemistry 1982, 21, 1160.
Matsuda, Y. Kita, J. Am. Chem. Soc. 2004, 126, 11800; b) H.
Fujioka, T. Okitsu, Y. Sawama, N. Murata, R. Li, Y. Kita, J. Am.
Chem. Soc. 2006, 128, 5930.
[24] Common deacetalization conditions with Brønsted acids failed
to promote the desired transformation.
[25] a) G. A. Molander, Chem. Rev. 1996, 96, 307; b) D. J. Edmonds,
D. Johnston, D. J. Procter, Chem. Rev. 2004, 104, 3371; c) K. C.
Nicolaou, S. P. Ellery, J. S. Chen, Angew. Chem. Int. Ed. 2009, 48,
7140; Angew. Chem. 2009, 121, 7276.
[26] a) G. P. Boldrini, L. Lodi, E. Tagliavini, C. Tarasco, C. Trombini, [28] For notable exceptions, see Ref. [16d] and a) C. Li, X. Yu, X. Lei,
A. Umanironchi, J. Org. Chem. 1987, 52, 5447; b) M. K. Org. Lett. 2010, 12, 4284.
Chaudhuri, S. K. Dehury, S. Hussain, Tetrahedron Lett. 2005,
46, 6247.
[27] The treatment of 1 with Zn0 in acetic acid at reflux gave 11b,13-
dihydroxerantholide in 60 % yield. This transformation allows Manuscript received: November 15, 2016
access to mikanokryptin-type guaianolides without C6 hydrox- Final Article published: && &&, &&&&
Angew. Chem. Int. Ed. 2017, 56, 1 – 6 ! 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.angewandte.org 5
!
!
Communications
Natural Products Synthesis
X. Hu, S. Xu,
T. J. Maimone* &&&— &&&
6 www.angewandte.org ! 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Angew. Chem. Int. Ed. 2017, 56, 1 – 6
!
!